About PathAI
Industry:
AI/Digital Pathology
Founded:
2016
Founders:
Andy Beck, Aditya Khosla
Status:
Private
Funding & Growth
Total Raised:
$400M+
Valuation:
$1.5B+
Stage:
Series D
Key Investors:
Tiger Global
General Atlantic
Merck
Bristol-Myers Squibb
✓ Pros
- • Leading AI pathology company
- • Strong pharma partnerships
- • Top-tier ML talent
- • Boston biotech hub
- • Mission-driven work
✗ Cons
- • Startup intensity
- • Path to profitability unclear
- • Regulatory challenges
- • Competitive AI market